open access

Vol 10, Supp. G (2014)
suplement
Published online: 2015-03-23
Get Citation

Multiple osteolitic leasions in course of the adenocarcinoma of the lung — diagnostics and treatment

Maja Wasylecka-Morawiec, Adam Płużański

open access

Vol 10, Supp. G (2014)
suplement
Published online: 2015-03-23

Abstract

Multiple osteolytic lesions suggest primary bone disease, chronic inflammatory condition or may rise the suspicion of metastatic malignancy. In this paper, we describe the diagnostic process in a 32-year old female with multiple osteolytic lesion in the skeletal system. As a result, we diagnosed advanced pulmonary adenocarcinoma with EGFR mutation. Treatment with the EGFR tyrosine kinase inhibitor resulted in objective response, performance status improvement and ameliorated metastasis-associated pain.

Abstract

Multiple osteolytic lesions suggest primary bone disease, chronic inflammatory condition or may rise the suspicion of metastatic malignancy. In this paper, we describe the diagnostic process in a 32-year old female with multiple osteolytic lesion in the skeletal system. As a result, we diagnosed advanced pulmonary adenocarcinoma with EGFR mutation. Treatment with the EGFR tyrosine kinase inhibitor resulted in objective response, performance status improvement and ameliorated metastasis-associated pain.

Get Citation

Keywords

non-small cell lung cancer, bone metastases, tyrosine kinase inhibitor

About this article
Title

Multiple osteolitic leasions in course of the adenocarcinoma of the lung — diagnostics and treatment

Journal

Oncology in Clinical Practice

Issue

Vol 10, Supp. G (2014)

Pages

38-41

Published online

2015-03-23

Keywords

non-small cell lung cancer
bone metastases
tyrosine kinase inhibitor

Authors

Maja Wasylecka-Morawiec
Adam Płużański

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl